Cross-Border Impact Ventures is an impact venture capital firm dedicated to revolutionizing health technology investing. They focus on world-class companies developing medical devices, diagnostics, therapeutics, and digital health innovations that improve health outcomes for women, children, and adolescents globally. The firm invests in four key sectors: sexual and reproductive health, maternal, newborn and child health, general health (including chronic diseases), and health software infrastructure. They prioritize companies addressing gender health inequalities and seek opportunities that yield both high impact and high financial returns. Cross-Border Impact Ventures acts as enablers, leveraging deep expertise in health technology and global markets to support their portfolio companies with access to new markets and capital, thereby accelerating the delivery of cutting-edge technologies to underserved communities.
Hardware / software
Investment focus
Investment style
Specialist
Latest fund size
$58M (Fund II, first close)
Latest fund vintage
2026
Data last enriched
Aug 14, 2026
Investing team
- Annie TheriaultManaging Partner
- Donna ParrManaging Partner
- Megan DoverPartner
- Femke SmeetsManaging Director of Emerging Markets
- Issy GordonInvestment Director
- Pooja SikkaVenture Partner